News

Men with non-metastatic forms are likely to live 'for many years' after diagnosis when active surveillance and other NCCN ...
Real-world data suggest that Erleada may offer an advantage over other treatment options for patients with metastatic ...
Patients with nonmetastatic prostate cancer treated according to NCCN Guidelines are more likely to die of other natural ...
Journal of the National Comprehensive Cancer Network finds that for people diagnosed with nonmetastatic low-risk prostate ...
A study out of Sweden finds that people diagnosed with localized prostate cancer are unlikely to die from the cancer if they ...
A highly effective and “minimally invasive” prostate cancer treatment is “disappearing” from private hospitals in New Zealand ...
Prostate cancer focal therapies include cryotherapy, irreversible electroporation ablation (IRE), & high-intensity focused ultrasound (HIFU).
A Florida man kept a promise to his father by completing a cross-country cycling race as his dad simultaneously underwent ...
A study out of Sweden finds that people diagnosed with localized prostate cancer are unlikely to die from the cancer if they ...
The addition of metformin “was generally well tolerated but did not result in the targeted benefit of a 20% reduction in risk of death in an unselected population,” the researchers wrote.
House Oversight Committee Chair James Comer is questioning the former White House physician Kevin O’Connor’s decision to ...
Telix Pharmaceuticals Limited (NASDAQ:TLX) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds.